Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3927]
News [11447]
Articles [47]
Editorials [10]
Conferences [200]
elearning [4]
Cancer Survivorship
Dr Lidia Schapira - Stanford Medicine, California, USA
Cancer Survivorship ( Dr Lidia Schapira - Stanford Medicine, California, USA )
20 Apr 2023
Encouraging safety and efficacy for REGN5459, a BCMA×CD3 bispecific antibody...
Dr Attaya Suvannasankha - Indiana University Melvin and Bren Simon Cancer...
Encouraging safety and efficacy for REGN5459, a BCMA×CD3 bispecific antibody with low CD3 affinity, in patients with RRMM ( Dr Attaya Suvannasankha - Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, USA )
20 Apr 2023
Cancer Care in Older Adults and Special Population
Dr Don Dizon - Rhode Island Hospital, Rhode Island, USA
Cancer Care in Older Adults and Special Population ( Dr Don Dizon - Rhode Island Hospital, Rhode Island, USA )
20 Apr 2023
Why tumour markers are not recommended as screening tests
Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines
Why tumour markers are not recommended as screening tests ( Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines )
20 Apr 2023
ALLO-316 demonstrates encouraging anti-tumour activity for patients with...
Dr Samer Srour - The University of Texas MD Anderson Cancer Center, Houston, USA
ALLO-316 demonstrates encouraging anti-tumour activity for patients with advanced or metastatic ccRCC ( Dr Samer Srour - The University of Texas MD Anderson Cancer Center, Houston, USA )
20 Apr 2023
Addition of Salmonella-IL2 to FOLFIRINOX for metastatic stage 4 pancreatic...
Prof Daniel Saltzman - University of Minnesota, Minneapolis, USA
Addition of Salmonella-IL2 to FOLFIRINOX for metastatic stage 4 pancreatic cancer nearly doubles median survival ( Prof Daniel Saltzman - University of Minnesota, Minneapolis, USA )
20 Apr 2023
Atezo plus bev demonstrates efficacy in preventing recurrence in patients with...
Prof Pierce Chow - Duke-NUS Medical School, Singapore
Atezo plus bev demonstrates efficacy in preventing recurrence in patients with high-risk HCC ( Prof Pierce Chow - Duke-NUS Medical School, Singapore )
20 Apr 2023
A single fractionated cycle of 225Ac-J591 shows preliminary efficacy on mCRPC...
Dr Jones Nauseef - Weill Cornell Medicine, New York City, USA
A single fractionated cycle of 225Ac-J591 shows preliminary efficacy on mCRPC patients ( Dr Jones Nauseef - Weill Cornell Medicine, New York City, USA )
20 Apr 2023
IO-108 shows promising results in the treatment of advanced relapsed or...
Dr Matthew Taylor - Providence Cancer Institute, Portland, USA
IO-108 shows promising results in the treatment of advanced relapsed or refractory solid tumours ( Dr Matthew Taylor - Providence Cancer Institute, Portland, USA )
20 Apr 2023
Higher BMI may be linked with worse survival among SBS88 positive CRC patients
Dr Claire Thomas - Fred Hutchinson Cancer Center, Seattle, USA
Higher BMI may be linked with worse survival among SBS88 positive CRC patients ( Dr Claire Thomas - Fred Hutchinson Cancer Center, Seattle, USA )
20 Apr 2023
MatchMiner: An open-source AI precision medicine trial matching platform
Dr Harry Klein - Dana Farber Cancer Institute, Boston, USA
MatchMiner: An open-source AI precision medicine trial matching platform ( Dr Harry Klein - Dana Farber Cancer Institute, Boston, USA )
20 Apr 2023
Test identifies tumour-infiltrating cell densities as prognostic biomarkers...
Dr James Lindsay - Dana Farber Cancer Institute, Boston, USA
Test identifies tumour-infiltrating cell densities as prognostic biomarkers across a pan-cancer cohort ( Dr James Lindsay - Dana Farber Cancer Institute, Boston, USA )
20 Apr 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation